Claire MONGE
Equipe : Vecteurs colloïdaux et ingénierie thérapeutique ciblée
Courriel : claire.monge@ibcp.fr
Téléphone : +33(0)4-72-72-26-90
Statut : Chargé de recherches
24 publications au total. Seules les 5 dernières années sont affichées
2021
24. Seaweed Sulfated Polysaccharides against Respiratory Viral Infections.
Jabeen M, Dutot M, Fagon R, Verrier B, Monge C
(2021) Pharmaceutics 13 :
23. Sublingual antigen delivery: a solution for needle-free HIV vaccination.
Monge C, Verrier B
(2021) Expert Rev Vaccines 20 :1047-1050
22. Sublingual protein delivery by a mucoadhesive patch made of natural polymers.
Paris Al, Caridade S, Colomb E, Bellina M, Boucard E, Verrier B, Monge C
(2021) Acta Biomater 128 :222-235
21. Sublingual vaccination and delivery systems.
Paris Al, Colomb E, Verrier B, Anjuère F, Monge C
(2021) J Control Release 332 :553-562
2019
20. Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation.
Coolen Al, Lacroix C, Mercier-gouy P, Delaune E, Monge C, Exposito Jy, Verrier B
(2019) Biomaterials 195 :23-37
2017
19. Nanoparticle-Based Dressing: The Future of Wound Treatment?
Berthet M, Gauthier Y, Lacroix C, Verrier B, Monge C
(2017) Trends Biotechnol 35 :770-784
18. Quiescence of human muscle stem cells is favored by culture on natural biopolymeric films.
Monge C, Distasio N, Rossi T, Sebastien M, Sakai H, Kalman B, Boudou T, Tajbakhsh S, Marty I, Bigot A, Mouly V, Picart C
(2017) Stem Cell Res Ther 8 :104-104
